P00519 (ABL1_HUMAN) Homo sapiens (Human)

Tyrosine-protein kinase ABL1 UniProtKBInterProSTRINGInteractive Modelling

1130 aa; Sequence (Fasta) ; (Isoform 2; ) Identical sequences: Homo sapiens: A0A024R8E2

Sequence Features

 363Proton acceptor
 47R -> G (in a lung large cell carcinoma sample; somatic mutation) VAR_032676
 140L -> P (in dbSNP:rs1064152) VAR_051692 dbSNP
 166R -> K (in a melanoma sample; somatic mutation) VAR_032677
 226Y -> C (in CHDSKM; increases kinase activity; no effect on protein levels; dbSNP:rs1060499547) VAR_079482 dbSNP
 247K -> R (in dbSNP:rs34549764) VAR_051693 dbSNP
 337A -> T (in CHDSKM; increases kinase activity; no effect on protein levels; dbSNP:rs1060499548) VAR_079483 dbSNP
 706G -> V (in dbSNP:rs34634745) VAR_025043 dbSNP
 810P -> L (in dbSNP:rs2229071) VAR_032678 dbSNP
 852T -> P VAR_025044
 900P -> S (in dbSNP:rs35266696) VAR_025045 dbSNP
 968S -> P (in dbSNP:rs1064165) VAR_051694 dbSNP
 972S -> L (in dbSNP:rs2229067) VAR_025046 dbSNP
 248-256ATP
 316-322ATP
 26-27Breakpoint for translocation to form BCR-ABL and NUP214-ABL1 fusion proteins
 67-113SH3 domain
IPR001452PF00018
 127-202SH2 domain
IPR000980PF00017
 242-492Serine-threonine/tyrosine-protein kinase, catalytic domain
IPR001245PF07714
 1026-1130F-actin binding
IPR015015PF08919

Sequence Alignments

Experimental structures

DescriptionOligo-stateLigandsStructureRangeDownloadAssess
Crystal structure of monobody SH13/ABL1 SH2 domain complex Heteromer
SO4;3uyo115-228
CRYSTAL STRUCTURE OF MONOBODY AS25/ABL1 SH2 DOMAIN COMPLEX, CRYSTAL A Heteromer
P02751;
GOL;5dc4121-220
CRYSTAL STRUCTURE OF MONOBODY AS25/ABL1 SH2 DOMAIN COMPLEX, CRYSTAL B Heteromer
P02751;
GOL;IMD;5dc9121-220
Crystal Structure of Monobody HA4/Abl1 SH2 Domain Complex Heteromer
PO4;3k2m121-220
Crystal structure of monobody 7c12/abl1 sh2 domain complex Heteromer
GOL;SO4;3t04122-219
CRYSTAL STRUCTURE OF MONOBODY GG3/ABL1 SH2 DOMAIN COMPLEX Heteromer
P02751;
5dc0122-219
Crystal structure of the Abl-SH3 domain complexed with the high affinity peptide P0 Heteromer
Q9Y3L3;
SO4;GOL;4j9f62-121
Ternary complex of an Crk SH2 domain, Crk-derived phophopeptide, and Abl SH3 domain by NMR spectros… Heteromer
P46108; Q64010;
1ju562-121
Crystal structure of the N114A mutant of the Abl-SH3 domain complexed with the high affinity peptid… Heteromer
Q9Y3L3;
SO4;4j9d62-120
A Src-like Inactive Conformation in the Abl Tyrosine Kinase Domainhomo-4-mer ADP;2g2i229-502
Structural basis for the auto-inhibition of c-Abl tyrosine kinasehomo-2-mer MYR;P16;1opl62-512
C-abl Kinase domain with the activator(cmpd6), 2-cyano-N-(4-(3,4-dichlorophenyl)thiazol-2-yl)acetam…homo-2-mer SO4;STI;KWD;2PE;6npe232-511
C-abl Kinase domain with the activator(cmpd29), N-(1-(3,4-dichlorophenyl)-4,5-dihydro-1H-pyrazol-3-…homo-2-mer STI;KWV;SO4;GOL;2PE;6npu232-510
The crystal structure of human abl1 kinase domain in complex with DCC-2036homo-2-mer NA;919;3qri229-498
The crystal structure of human abl1 kinase domain T315I mutant in complex with DCC-2036homo-2-mer 919;3qrj233-497
Crystal structure of the N114Q mutant of ABL-SH3 domain complexed with a designed high-affinity pep…homo-2-mer SO4;3eg164-121
Organization of the SH3-SH2 Unit in Active and Inactive Forms of the c-Abl Tyrosine Kinasemonomer MYR;P16;GOL;2fo046-511
ABL1 kinase (T334I_D382N) in complex with asciminib and nilotinibmonomer NIL;AY7;5mo464-512
Structure of the Kinase Domain of an Imatinib-Resistant Abl Mutant in Complex with the Aurora Kinas…monomer VX6;2f4j227-513
A Src-like Inactive Conformation in the Abl Tyrosine Kinase Domainmonomer 112;2g2f232-506
Crystal structure of the c-Abl kinase domain in complex with INNO-406monomer 406;2e2b229-502
Crystal structure of an SH2-kinase domain construct of c-Abl tyrosine kinasemonomer 1N1;4xey231-503
A Src-like Inactive Conformation in the Abl Tyrosine Kinase Domainmonomer P16;2g2h233-504
X-ray Crystal Structure of Dasatinib (BMS-354825) Bound to Activated ABL Kinase Domainmonomer 1N1;2gqg229-500
Crystal structure of ABL1 in complex with CHMFL-074monomer 66K; 12×EDO;CL;5hu9229-499
A Src-like Inactive Conformation in the Abl Tyrosine Kinase Domainmonomer MG;112;2g1t232-502
The crystal structure of human abl1 T315I gatekeeper mutant kinase domain in complex with axitinibmonomer AXI;NI;NA;4twp233-503
Crystal structure of the T315I Abl mutant in complex with the inhibitor PHA-739358monomer 627;MG;2v7a233-503
Crystal Structure of Inactive Conformation Abl Kinase Catalytic Domain Complexed with Type II Inhib…monomer 7MP;2hiw230-499
Structural and spectroscopic analysis of the kinase inhibitor bosutinib binding to the Abl tyrosine…monomer DB8;3ue4233-502
Predicting the Conformational Variability of Abl Tyrosine Kinase Using Molecular Dynamics Simulatio…monomer PVB;SO4;6bl8233-502
Discovery and Characterization of a Cell-Permeable, Small-molecule c-Abl Kinase Activator that Bind…monomer SO4;STI;3YY;3pyy232-500
C-abl Kinase domain with the activator(cmpd51), N-(1-(3,4-dichlorophenyl)-4-(2-hydroxyethyl)-4,5-di…monomer SO4;STI;KWP;6npv232-500
VX-680/MK-0457 binds to human ABL1 also in inactive DFG conformations.monomer VX6;MXE;4zog233-501
C-Helix-Out Binding of Dasatinib Analog to c-Abl Kinasemonomer 4B7;EDO;MES;4yc8233-501
Abl kinase domain in complex with PD180970monomer JIN;2hzi233-500
Human ABL kinase in complex with nilotinibmonomer NIL;3cs9233-500
The crystal structure of human abl1 kinase domain in complex with DP-987monomer 9DP;3qrk229-496
Abl kinase domain unligated and in complex with tetrahydrostaurosporinemonomer 4ST;2hz4234-500
Abl kinase domain in complex with NVP-AEG082monomer GIN;2hz0233-497
Human Abl kinase domain in complex with imatinib (STI571, Glivec)monomer STI;2hyy235-498
The crystal structure of human abl1 wild type kinase domain in complex with axitinibmonomer AXI;4wa9246-508
Abl1b Regulatory Module 'Activating' conformationmonomer 6amw6-236
Abl 1b Regulatory Module 'inhibiting statemonomer 6amv6-236
SH3-SH2 DOMAIN FRAGMENT OF HUMAN BCR-ABL TYROSINE KINASEmonomer 2abl57-218
Solution structure of the F-actin binding domain of Bcr-Abl/c-Ablmonomer 1zzp1024-1130
THREE-DIMENSIONAL SOLUTION STRUCTURE OF THE SRC HOMOLOGY 2 DOMAIN OF C-ABLmonomer 1ab2120-220
Crystal structure of the N114A mutant of ABL-SH3 domainmonomer GOL;3eg360-121
Crystal structure of the N114A Abl-SH3 domain mutant at pH4monomer PEG;NA;4jjd60-121
Crystal structure of the N114Q mutant of ABL-SH3 domainmonomer GOL;3eg260-121
Crystal structure of the Abl-SH3 domain at pH 7.5monomer PEG;5oaz62-120
Crystal structure of the ABL-SH3 domain complexed with the designed high-affinity peptide ligand P7…monomer SO4;4j9h62-120
Crystal structure of the Abl-SH3 domain H59Q-N96T mutant complexed with the designed high-affinity …monomer PGE;PEG;4j9c63-120
Crystal structure of the Abl-SH3 domain at pH5monomer PEG;4jjc64-121
CRYSTAL STRUCTURE OF THE ABL-SH3 DOMAIN COMPLEXED WITH A DESIGNED HIGH-AFFINITY PEPTIDE LIGAND: IMP…monomer SO4;1bbz64-121
Crystal structure of the Abl-SH3 domain H59Q-N96T mutantmonomer PEG;4j9b63-120
Crystal structure of the N114A mutant of ABL-SH3 domain complexed with a designed high-affinity pep…monomer SO4;2o8864-121
Crystal structure of the N114A mutant of the Abl-SH3 domain complexed with the high affinity peptid…monomer SO4;4j9e64-120
Crystal structure of the Abl-SH3 domain at pH3monomer PEG;SO4;4jjb64-120
Crystal structure of the ABL-SH3 domain complexed with the designed high-affinity peptide ligand P7…monomer SO4;GOL;4j9g63-119
Crystal structure of the ABL-SH3 domain complexed with the designed high-affinity peptide ligand P17monomer GOL;4j9i64-120
Crystal structure of the N114A mutant of ABL-SH3 domainmonomer SO4;GOL;3egu63-119
THE SOLUTION NMR STRUCTURE OF ABL SH3 AND ITS RELATIONSHIP TO SH2 IN THE SH(32) CONSTRUCT, 20 STRUC…monomer 1awo64-120
Abl1 SH3 pTyr89/134monomer 5np264-119
Crystal structure of the N114T mutant of ABL-SH3 domainmonomer GOL;3eg064-119

Homology models built on isoform sequence

Isoform #Oligo-stateLigandsQMEANTemplateRangeSeq id (%)ReportDownloadAssess
2monomerMYR;P16;0.652fo0.1.A65-530
99.80
2monomerP16;0.131opl.2.A140-518
99.44
2monomer-3.961zzp.1.A1043-1149
99.19
2monomer-3.232yt6.1.A80-157
37.66
2monomer-0.924le9.1.A84-137
52.83